Discover how cloud-based High-Performance Computing (HPC) is transforming life sciences by eliminating the bottlenecks of legacy on-prem infrastructure. From AI-driven drug discovery to genome analysis, learn why now is the time to migrate to scalable, secure, and cost-effective HPC solutions in the cloud.

Life sciences organizations are navigating unprecedented data complexity, regulatory scrutiny, and the demand for faster, more insightful decision-making. This exclusive white paper outlines how domain-specific Agentic AI—autonomous, purpose-built agents—can move beyond point solutions to drive end-to-end transformation across R&D, clinical operations, regulatory affairs, and commercial functions.

In this episode, Craig Lipset—clinical trials innovator and Co-Chair of DTRA—joins Nagaraja Srivatsan to unpack how AI can make trials more predictable, productive, and human-centered. From managing digital teammates to embracing grassroots experimentation, hear how life sciences can navigate AI adoption with confidence.

Revolutionizing Pharma Commercialization with Agilisium's AI Agents

In celebration of Women’s Day, Agilisium is hosting a special edition of our Women’s Thought Leadership Series—a high-impact panel discussion on “Women Shaping the Future of Pharma & Tech”.